ORCL has steadied slightly from last week's low, closing Tuesday at $119.96, yet the short position that exploded 30% in a single week has barely retreated — and the stock remains 42% below where it traded the day before June earnings.
The short interest story has evolved since last week's note documented the sharpest single-session build since the earnings collapse. Estimated shorts now sit at around 50 million shares, roughly 1.76% of the free float — up 30% on the week and 41% over the past month. The week-on-week addition has largely held rather than unwound, suggesting the new entrants from the July 23-24 spike are staying put. Cost to borrow has ticked up 50% on the week to 0.34%, which still qualifies as negligible in absolute terms. Borrow availability remains essentially unlimited — the lending pool dwarfs current short demand by a factor of thousands — so there is no squeeze mechanism forming. The build continues to look like directional conviction, not a mechanical event. Options traders are incrementally less defensive than the 20-day average suggests: the put/call ratio of 0.82 sits just below the 0.87 mean. That mild call lean has persisted for three consecutive weeks even as the stock drifts lower, a divergence worth watching but not yet an actionable signal.
The gap between where the stock trades and where the Street thinks it belongs has become the dominant tension on this name. The analyst consensus target averages $248 — more than double Tuesday's close — implying roughly 107% upside at current levels. CLSA initiated coverage on July 20 with a Hold and a $145 target, the most cautious recent addition to the coverage universe. Most of the post-earnings cluster of notes from mid-June maintained Buy or Overweight ratings, with targets ranging from $225 to $400 — a spread that reflects genuine disagreement about how to value Oracle's AI infrastructure acceleration. The bull case centres on cloud revenue growing 41% year-on-year to $8.9 billion, AI infrastructure up 243%, and remaining performance obligations up 325%. Bears point to intensifying competition, AI monetization risk, and the stock's failure to respond positively even to a $6.99 billion Pentagon contract awarded last week. The PE multiple has compressed roughly 21% over 30 days to 12.4x, making the valuation case arithmetically simpler — but the market is clearly demanding evidence of execution before re-rating.
Institutional ownership offers a structural footnote: Larry Ellison holds 40% of shares outstanding, a concentration that mechanically limits the free float and amplifies price moves. The most recent 90-day insider net activity shows net selling of roughly $66 million, driven by Executive Vice Chairman Jeffrey Henley, who sold approximately $51 million across multiple tranches on June 24 at prices between $156 and $166 — well above current levels. That selling occurred before the latest leg lower and does not represent fresh bearish action, but it is a reminder that insiders were distributing at prices the stock has since moved significantly below.
Among correlated peers, the contrast this week is stark. NOW gained 8.4% on the week and NTNX rose 9.0%, while ORCL fell 5.6% and RBRK dropped 5.7%. The enterprise software complex is not uniformly under pressure — the divergence increasingly looks company-specific rather than sector-wide. The earnings reaction history adds context: the June 10 print produced a 10.5% single-day decline and a 10.8% five-day drop; the prior quarter saw a 3.7% day-one fall extending to 9.8% over five sessions. The next scheduled print is September 4.
The key question between now and September 4 is whether the short interest build consolidates further or begins to fade as the stock attempts to find a base above $115 — the level that held as last week's close before this week's modest bounce.
See the live data behind this article on ORTEX.
Open ORCL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
